MUCOADHESIVE DRUG DELIVERY SYSTEM
PRESENTED BY MRS.KAMBLE V.H.
GUIDEDE BYMISS.DASWADKAR S.C.
PAD.DR.D.Y.PATIL COLLEGE OF PHARMACY AKURDI PUNE.
04/05/2016 1
Contents
04/05/2016 2
What is mucus ? Inner layers called mucosa Covered with viscoelastic fluid. This
fluid Secreted by Goblet cells and it composed of water and mucin.
Other components include proteins, lipids and mucopolysaccharides ,electrolytes
04/05/2016 3
What is mucus ?DIMENSIONThickness varies from 40 μm to 300 μmGeneral composition of mucus•Water…………………………………..95%•Glycoprotein and lipids……………..0.5-5%•Mineral salts……………………………1%•Free proteins…………………………..0.5-1%
04/05/2016 4
Functions
04/05/2016 5
Protective
Barrier
Adhesion
Lubrication
Mucoadhesive drug delivery system
Mucoadhesive drug delivery system interact with the mucus layer covering the mucosal epithelial surface, & mucin molecules & increase the residence time of the dosage form at the site of the absorption. Mucoadhesive drug delivery system is a part of controlled delivery system.
Hydrophilic high mol. wt. such as peptides that cannot be administered & poor absorption ,then MDDS is best choice.
04/05/2016 6
Avoidance of
First pass Metabolism
Better absorption of peptide by
penetration enhancer
Prolong
residence time
Localization of drug at given site
WHY ?
04/05/2016 7
Theories Mucoadhesion
04/05/2016 8
MECHANISMS OF MECHANISMS OF MUCOADHESIONMUCOADHESION
STAGE -I
STAGE-II
STAGE -III
04/05/2016 9
MUCOADHESIVE POLYMER They are water soluble and water insoluble polymers which are
swellable networks joined by cross linking agentCHARACTERISTIC OF IDEAL POLYMER Degradation products should be non toxic and non absorbable
from GIT Good spreadibility, wetting, swelling and biodegradable
properties Optimum molecular weight Non irritant to mucous membrane Form a strong non-covalent bond with mucin epithelial cell
surface
04/05/2016 10
Polymer classification
04/05/2016 11
PENETRATION ENHANCER Substances that facilitate the permeation through mucosa are
referred as permeation enhancers .
Safe and non toxic, non irritating and non allergenic
Pharmacologically and chemically inert
04/05/2016 12
DIFFERENT ROUTES OF TARGETING MDDS
04/05/2016 13
Prolongation of residence of drug in GIT.Targeting & localization of the dosage form at a specific sitePainless administration.Low enzymatic activity & avoid of first pass metabolism
Advantages
Drug , which irritate the oral mucosa ,have a bitter or unpleasant taste ,odor cannot be administer by this rout. Some patient suffers unpleasant feeling.Costly drug delivery system.
Disadvantages
04/05/2016 14
Mucoadhesive dosage form
Mucoadhesive
dosage form
LiquidSuspensionsGel forming liquids
SolidTabletsMatrix tabletMucoadhesive micro particles /microspeare Bioadhesive inserts
SemisolidGels & ointmentFilmsPatches
04/05/2016 15
MUCOADHESIVE MICROSPHERES A controlled release system designed to increase its
residence time in the stomach with contact with the mucosa was achieved through the preparation of Mucoadhesive microspheres
Microspheres are small spherical particles (typically 1 μm to 1000 μm), sometimes referred to as micro particles. The microspheres can be made up of either natural or synthetic polymers.
04/05/2016 16
Method of preparation
04/05/2016 17
Coating material phase
Core material phase
Phase separation
1.Complex coacervation
2.Hot melt microencapsulation
04/05/2016 18
3.Solvent evaporation method
04/05/2016 19
4.Spray drying
04/05/2016 20
Drug loading DRUG LOADING IN MICROSPHERE The drugs are loaded in the microspheres principally using two
methods i.e. during the preparation of the microsphere or after the preparation of the microsphere
The loading of drug after the preparation of microspheres may be achieved by incubating them with high concentration of the drug in a suitable solvent.
04/05/2016 21
METHODS OF EVALUATION
04/05/2016 22
CASE STUDY • Design and evaluation of Mucoadhesive microspheres of
repaglinide for oral controlled release by Vimal K. Yadav, Brajesh Kumar, S.K. Prajapati , Kausar shafaat
• They devlope,characterize and evaluate Mucoadhesive microspheres of repaglinide employing Mucoadhesive polymer for prolonged GIT absorption.
• Method used=Solvent evaporation method
• Polymer used =Eudragit RS-100 and chitosan
04/05/2016 23
• Other ingredient used =liquid paraffin,acetone,magnesium sterate,methanol,DCM.
• Stirring speed =1000 rpm
• Conclusion =drug loaded Mucoadhesive microsphere are sutaible for repaglinide.
04/05/2016 24
Sustained release dosage form is essential for diabetic patient which marked by continues therapy along with high margin of safety, patient compliance and fulfil economical feature.
PROBLEM WITH REPAGLINIDE Its have very short biological half life Low bioavailability about 50% Poor absorption in upper intestinal tract So it is indicated for the development of dosage form with
increase gastric residence time
04/05/2016 25
Material Repaglinide
Sodium alginate
Carbapol 334
Calcium chloride
Chloroform
04/05/2016 26
Method of preparation of microsphere Method used ionic gelation method Stirring speed=1000rpmMethod
04/05/2016 27
Formula
04/05/2016 28
Formulation code
Drug Sodium alginate
Carbapol334
Calcium chloride
chloroform
F1 50 mg
1% 0.5% 15% 100 ML
• Particle size-determine by using optical microscope
04/05/2016 29
04/05/2016 30
• Particle under compound microscope
04/05/2016 31
04/05/2016 32
Sr no Particle size in micrometre
1 35.47
2 38.9
3 27.2
4 41.23
5 43.42
6 47.51
SURFACE MORPHOLOGY Particle is rough irregular shape most of circular shape.
FURTHER STUDY To prepare various formulation of mucoadhesive microsphre and select best formulation .
ReferencesGarg Ankita , Upadhyay Prashant ,Mucoadhesive microspheres: a
short review ,Published by Asian Journal of Pharmaceutical and Clinical Research, Vol 5, Suppl 3, 2012, ISSN - 0974-2441.
Tangri Pranshu , Mucoadhesive drug delivery: mechanism and methods of evaluation, Published by International Journal of Pharma and Bio Sciences,Vol-2/Issue-1/Jan-March-2011,ISSN 0975-6299
Flávia Chiva Carvalho , Marcos Luciano Bruschi et al , Mucoadhesive drug delivery systems, Published by Brazilian Journal of Pharmaceutical Sciences, vol. 46, n. 1, jan./mar., 2010.
04/05/2016 33
Yadav Vimal K.,Kumar Brajesh,Prajapati S.K.,shafaat Kausar, Design and evaluation of Mucoadhesive microspheres of repaglinide for oral controlled release,Published by International Journal of Drug Delivery 3 (2011) 357-370, ISSN: 0975-021.
Nazir Imran, Bashir Sajid et al, Development and Evaluation of Sustained Release Microspheres of Repaglinide for Management of Type 2 Diabetes Mellitus,Published By, Journal of Pharmacy and Alternative Medicine, Vol 1, 2012, ISSN 2222-4807
04/05/2016 34
04/05/2016 35